SCHEMBL9340449

SCHEMBL9340449

CCCCC(C)(O)C1CCCCN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.35
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CXCR4 P61073 1/20 0.35
CYP1A2 P05177 2/20 0.34
PRCP P42785 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
FDPS P14324 1/20 0.33
SLC6A2 P23975 3/20 0.32
SLC6A4 P31645 3/20 0.32
SLC6A3 Q01959 3/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21191731 0.82 CYP1A2 (0.36) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL22461930 0.82 FDPS (0.36) CCR2CYP1A2KDM4ENPC1CYP2D6
SCHEMBL7498448 0.82 FDPS (0.36) CCR2CYP1A2KDM4ENPC1CYP2D6
SCHEMBL22023884 0.79 CYP1A2 (0.34) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL21191705 0.79 CCR2 (0.37) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL26653572 0.79 CYP1A2 (0.34) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL28802145 0.79 PRCP (0.41) CYP1A2PRCPKDM4ENPC1CYP2D6
SCHEMBL23634135 0.77 CCR2 (0.38) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL22024596 0.77 CCR2 (0.38) CCR2CCR1CCR5CXCR4CYP1A2
SCHEMBL21707875 0.77 PRCP (0.35) CYP1A2PRCPKDM4ENPC1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0600955-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-06-15 EP disclosed
WO-1993003725-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-03-04 WO disclosed